Nuclear medicine camera vendor Trionix will forgo exhibiting atthis year's Radiological Society of North America conference infavor of more specialized nuclear medicine meetings. The Twinsburg,OH-based company, known for its towering exhibit booth, has
Nuclear medicine camera vendor Trionix will forgo exhibiting atthis year's Radiological Society of North America conference infavor of more specialized nuclear medicine meetings. The Twinsburg,OH-based company, known for its towering exhibit booth, has decidedthat the expense and disruption of attending both the RSNA meetingin November and a European nuclear medicine meeting in Octoberwould put too much of a strain on corporate resources, accordingto president Chun Bin Lim.
Trionix introduced an upgrade to its Triad and Biad line ofgamma cameras at the Society of Nuclear Medicine in Toronto inJune. The company has decided to concentrate on refining the linerather than spend time moving exhibit booths and products aroundthe world, Lim said.
"When you go to a show, it tends to disrupt the entireorganization," Lim said. "Because of that, this yearwe decided not to go to the RSNA."
Instead, Trionix will head to the European Association of NuclearMedicine meeting in Lucerne, Switzerland in October. Trionix isparticipating heavily in that show and its exhibit booth willbe the largest at the meeting, Lim said.
Trionix's preference for the European show is both a sign ofthe company's growing emphasis on international sales, as wellas its desire to make the most of its marketing dollar by attendingmore focused conferences. The RSNA meeting's gargantuan size--andits inclusion of all radiology modalities--can be frustratingfor a single-modality vendor like Trionix.
"I'm not saying anything negative about RSNA. (Marketingto) radiology is just not very effective in getting our pointsacross," Lim said. "There are simply too many peopleand too many products."
Trionix's new product line includes the Triad XLT and BiadXLT, and the Biad Slimline, designed for siting in small rooms.Trionix conducted a promotional tour of Europe and Australia insupport of the products. The cameras, which have Food and DrugAdministration marketing clearance, are undergoing clinical validationprior to marketing.
Trionix is not concerned that its absence from the RSNA meetingwill generate rumors about the company's viability. Orders areup 80% over last year and the company is growing, according toLim.
"I don't worry about that kind of thing," Lim saidof market gossip. "Since the beginning of the company it'sbeen our policy not to pay attention to what other people say,particularly competitors."
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.